Cargando…

p53 and H‐ras Mutations and Microsatellite Instability in Renal Pelvic Carcinomas of NON/Shi Mice Treated with N‐Butyl‐N‐(4‐hydroxybutyl)‐nitrosamine: Different Genetic Alteration from Urinary Bladder Carcinoma

We previously reported p53 mutations to be frequent (greater than 70%), whereas both H‐ras mutations and microsatellite instability (MSI) were infrequent (about 10%), in urinary bladder carcinomas (UBCs) and their metastatic foci in the N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine (BBN)‐induced mouse uroth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gen, Hiroyuki, Yamamoto, Shinji, Morimura, Keiichirou, Min, Wei, Mitsuhashi, Makoto, Murai, Takashi, Mori, Satoru, Hosono, Motoko, Oohara, Tadao, Makino, Susumu, Wanibuchi, Hideki, Fukushima, Shoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926685/ https://www.ncbi.nlm.nih.gov/pubmed/11749692 http://dx.doi.org/10.1111/j.1349-7006.2001.tb02150.x

Ejemplares similares

Renal Pelvic Carcinoma which Shows Metastatic Potential to Distant Organs, Induced by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine in NON/Shi Mice
por: Murai, Takashi, et al.
Publicado: (1991)

Chemopreventive Effects of Bovine Lactoferrin on N‐Butyl‐N‐(4‐ hydroxybutyl)nitrosamine‐induced Rat Bladder Carcinogenesis
por: Masuda, Chikayoshi, et al.
Publicado: (2000)

Strain Differences in N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Bladder Carcinogenesis in Rats
por: Nakanowatari, Jun‐ichi, et al.
Publicado: (1988)

Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
por: Ito, N, et al.
Publicado: (1983)

The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice
por: Dai, Yuan-Chang, et al.
Publicado: (2017)

No Promoting Effect of Ethyl Tertiary-butyl Ether (ETBE) on Rat Urinary Bladder Carcinogenesis Initiated with N-Butyl-N-(4-hydroxybutyl)nitrosamine
por: Hagiwara, Akihiro, et al.
Publicado: (2013)

Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon
por: Hicks, R. M., et al.
Publicado: (1980)

Synergism of Environmental Carcinogens and Promoters on Bladder Cancer Development Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine in F344 Rats
por: Ono, Satoko, et al.
Publicado: (1992)

Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis
por: JIANG, TAIMAO, et al.
Publicado: (2016)

Loss of Heterozygosity in (Lewis×F344)F(1) Rat Urinary Bladder Tumors Induced with N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Followed by Dimethylarsinic Acid or Sodium L‐Ascorbate
por: Chen, Tianxin, et al.
Publicado: (1999)

DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium
por: Dahm, Hans Helmut, et al.
Publicado: (2016)

Inhibitory Effect of Tomato Juice on Rat Urinary Bladder Carcinogenesis after N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Initiation
por: Okajima, Eijiro, et al.
Publicado: (1998)

Promoting Effect of the Peroxisome Proliferator, Clofibrate, but Not Di(2‐ethylhexyl)phthalate, on Urinary Bladder Carcinogenesis in F344 Rats Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine
por: Hagiwara, Akihiro, et al.
Publicado: (1990)

Anti‐promoting Effect of Nordihydroguaiaretic Acid on N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine and Sodium Saccharin‐induced Rat Urinary Bladder Carcinogenesis
por: Yu, Akinori, et al.
Publicado: (1992)

Chemopreventive Effects of a Flavonoid Antioxidant Silymarin on N‐Butyl‐N‐(4‐ hydroxybutyl)nitrosamine‐induced Urinary Bladder Carcinogenesis in Male ICR Mice
por: Vinh, Pham Quang, et al.
Publicado: (2002)

Chemopreventive Efficacy of Piroxicam Administered Alone or in Combination with Lycopene and β‐Carotene on the Development of Rat Urinary Bladder Carcinoma after A N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Treatment
por: Okajima, Eijiro, et al.
Publicado: (1997)

Summation Effects of Uracil and Other Promoters on Epithelial Lesion Development in the F344 Rat Urinary Bladder Initiated by N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine
por: de Camargo, João Lauro Viana, et al.
Publicado: (1991)

Low Susceptibility of Long‐Evans Cinnamon Rats to N‐Butyl‐N‐(4‐hydroxybutyl)‐nitrosamine‐induced Urinary Bladder Carcinogenesis and Inhibitory Effect of Urinary Copper
por: Chone, Yoshifumi, et al.
Publicado: (2000)

Detection of γ-H2AX, a Biomarker for DNA Double-strand Breaks, in Urinary Bladders of N -Butyl- N -(4-Hydroxybutyl)-Nitrosamine-Treated Rats
por: Toyoda, Takeshi, et al.
Publicado: (2013)

Strain Differences in Sensitivity to the Promoting Effect of Sodium L‐Ascorbate in a Two‐stage Rat Urinary Bladder Carcinogenesis Model
por: Murai, Takashi, et al.
Publicado: (1997)

Time‐ and Dose‐dependent Induction of Invasive Urinary Bladder Cancers by N‐Ethyl‐N‐(4‐hydroxybutyl)nitrosamine in B6C3F(1) Mice
por: Tamano, Seiko, et al.
Publicado: (1991)

Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model
por: Furuya, Hideki, et al.
Publicado: (2020)

Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model
por: Hori, Shunta, et al.
Publicado: (2017)

Inhibition of Development of N, N′‐Dimethylhydrazine‐induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R,25‐Dihydroxyvitamin D(3)
por: Salim, Elsayed I., et al.
Publicado: (1997)

Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice
por: Morikawa, Takashi, et al.
Publicado: (2000)

Distribution of Seven N-Nitrosamines in Food
por: Park, Jong-eun, et al.
Publicado: (2015)

Risk assessment of N‐nitrosamines in food
por: Schrenk, Dieter, et al.
Publicado: (2023)

Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
por: Hua, Xiaohui, et al.
Publicado: (2023)

Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling
por: Kakehashi, Anna, et al.
Publicado: (2014)

Study of DNA methylation by tobacco-specific N-nitrosamines.
por: Castonguay, A, et al.
Publicado: (1985)

Hierarchical Composites to Reduce N-Nitrosamines in Cigarette Smoke
por: Li, Yan Yan, et al.
Publicado: (2015)

The in vivo Formation of N-Nitrosamines in the Rat Bladder and their Subsequent Absorption
por: Hawksworth, G., et al.
Publicado: (1974)

Rapid formation of carcinogenic N-nitrosamines in aqueous alkaline solutions.
por: Challis, B. C., et al.
Publicado: (1977)

Novel Study on N-Nitrosamines as Risk Factors of Cardiovascular Diseases
por: Sheweita, Salah A., et al.
Publicado: (2014)

Metabolism and DNA Adduct Formation of Tobacco-Specific N-Nitrosamines
por: Li, Yupeng, et al.
Publicado: (2022)

Interaction of N-nitrosamines with binuclear copper complexes for luminescent detection
por: Feng, Haosheng, et al.
Publicado: (2023)

Investigation on the Contents of N(ε)-carboxymethyllysine, N(ε)-carboxyethyllysine, and N-nitrosamines in Commercial Sausages on the Chinese Market
por: Wang, Wenjing, et al.
Publicado: (2023)

Potential alkylating agents from the oxidation of carcinogenic cyclic n-nitrosamines.
por: Challis, B. C., et al.
Publicado: (1973)

Pattern recognition analysis of a set of mutagenic aliphatic N-nitrosamines.
por: Nesnow, S, et al.
Publicado: (1985)

Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine
por: Fukushima, Shoji, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_s0m49q8f5po6bjrcd7mi3102qk